Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical ...

EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals ...

Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free robotic technology may define a new standard in minimally invasive surgery. By ...

Houston, TX, Nov. 14, 2024 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies ...

Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free robotic technology may define a new standard in minimally invasive surgery.

EndoQuest Robotics , a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has submitted an Investigational Device Exemption (IDE ...

EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has submitted an Investigational Device Exemption ...

EndoQuest Robotics Inc. has submitted an Investigational Device Exemption, or IDE, application for its pivotal colorectal clinical study. With its flexible robotic system, the privately held medical ...